On Monday, GeneDx Holdings Corp (NASDAQ: WGS) was 6.64% up from the session before settling in for the closing price of $101.6. A 52-week range for WGS has been $25.32 – $117.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 96.65% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 544.11%. With a float of $25.05 million, this company’s outstanding shares have now reached $28.71 million.
In an organization with 1000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 67.18%, operating margin of 1.5%, and the pretax margin is 0.43%.
GeneDx Holdings Corp (WGS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward GeneDx Holdings Corp stocks. The insider ownership of GeneDx Holdings Corp is 12.79%, while institutional ownership is 104.24%. The most recent insider transaction that took place on Jul 29 ’25, was worth 40,860. In this transaction CHIEF FINANCIAL OFFICER of this company sold 388 shares at a rate of $105.31, taking the stock ownership to the 3,757 shares. Before that another transaction happened on Jul 29 ’25, when Company’s Chief Executive Officer sold 2,154 for $105.31, making the entire transaction worth $226,838. This insider now owns 3,440 shares in total.
GeneDx Holdings Corp (WGS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 544.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 134.22% during the next five years compared to 96.65% growth over the previous five years of trading.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
You can see what GeneDx Holdings Corp (WGS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.59. Likewise, its price to free cash flow for the trailing twelve months is 3749.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.02, a number that is poised to hit 0.36 in the next quarter and is forecasted to reach 2.34 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
Let’s dig in a bit further. During the last 5-days, its volume was 1.81 million. That was better than the volume of 1.09 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 88.17%.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 84.98%, which indicates a significant decrease from 99.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 6.08 in the past 14 days, which was higher than the 6.02 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $80.42, while its 200-day Moving Average is $80.62.
